Evaluation of doravirine-based regimen population target in a large Italian clinical center
{{output}}
Background: Doravirine (DOR) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) approved for HIV-1 infection treatment. Because of its genetic barrier, DOR appears to be a good alternative in switch strategies compared t... ...
